Australia markets closed

Catalent, Inc. (CTLT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
132.31+2.72 (+2.10%)
At close: 1:01PM EST
132.00 -0.31 (-0.23%)
After hours: 03:09PM EST
Full screen
Trade prices are not sourced from all markets
Previous close129.59
Bid130.02 x 800
Ask132.34 x 800
Day's range129.21 - 135.10
52-week range91.87 - 142.64
Avg. volume960,560
Market cap22.65B
Beta (5Y monthly)1.32
PE ratio (TTM)41.65
EPS (TTM)3.18
Earnings date31 Jan 2022 - 04 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est159.42
  • Business Wire

    Catalent, Inc. to Present at the Stephens Annual Investment Conference

    SOMERSET, N.J., November 23, 2021--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will virtually present at the Stephens Annual Investment Conference at 11:00 a.m. ET on November 29, 2021.

  • Zacks

    Why Catalent (CTLT) is a Top Growth Stock for the Long-Term

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Motley Fool

    Catalent, inc (CTLT) Q1 2022 Earnings Call Transcript

    Good morning everyone and thank you for joining us today to review Catalent's first quarter 2022 financial results. Joining me on the call today are John Chiminski, Chair and Chief Executive Officer, and Tom Castellano, Senior Vice President and Chief Financial Officer. Slides 4 and 5 discuss Catalent's use of non-GAAP financial measures and our just issued earnings release provides reconciliations to the most directly comparable GAAP measures, please also refer to Catalent's Form 10-Q that will be filed with the SEC today for additional information on the risks and uncertainties that may bear on our operating results, performance and financial condition, including those related to the COVID-19 pandemic.